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“Fake Results”
The Reproducibility Crisis in Research
and Open Science Solutions

“It can be proven that
most claimed research
findings are false.”
— John P. A. Ioannidis, 2005

Those are the words of John Ioannidis (yo-NEE-dees) in a highly-cited article from
2005.
Now based at Stanford University, Ioannidis is a meta-scientist who conducts
“research on research” with the goal of making improvements.

Sources:
Ionnidis, John P. A. “Why Most Published Research Findings Are False.” PLoS
Medicine 2, no. 8 (August 2005): e124. doi: 10.1371/journal.pmed/0020124.
Wikipedia, s.v. “Meta-research.” Accessed March 14, 2017.
https://en.wikipedia.org/wiki/Meta-research.

“Reproducibility crisis”
(aka “replication crisis”)
“A methodological crisis in science in which
scientists have found that the results of many
scientific experiments are difficult or
impossible to replicate on subsequent
investigation, either by independent researchers
or by the original researchers themselves.”
— Wikipedia

A recent survey by Nature found that more than 70% of researchers have tried and
failed to reproduce another scientist’s experiments and more than half have failed to
reproduce their own experiments.
90% of respondents agreed there is a reproducibility crisis.

Source:
Baker, Monya. “Is There a Reproducibility Crisis?” Nature 533 (May 26, 2016):
452-454. doi: 10.1038/533452a.
Wikipedia, s.v. “Replication Crisis.” Accessed March 14, 2017.
https://en.wikipedia.org/wiki/Replication_crisis.

Psychology
91.5% of
all
published
studies in
psychology
found
positive
results.
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Psychology is one of the disciplines where the crisis has received the most attention.
It is also a field where 91.5% of all published studies found positive results, that is,
they supported the outcome predicted by researchers.
In 2015, the results of the Reproducibility Project: Psychology were published.
This was a four-year study lead by Brian Nosek, a professor of psychology at the
University of Virginia and the co-founder & executive director of the Center for Open
Science.
In the study, 270 authors replicated 100 social and cognitive psychology studies that
had been published in three top psychology journals in 2008.
While 97% of the original studies produced significant results, only 36% of the
replications did. Also, the effect sizes in the replication studies were only about half
that of the original studies.

Sources:
Fanelli, Daniele. “‘Positive’ Results Increase Down the Hierarchy of the Sciences.”
PLoS One 5, no. 4 (2010): e10068. doi: 10.1371/journal.pone.0010068.

Open Science Collaboration. “Estimating the Reproducibility of Psychological
Science.” Science 349, no. 6251 (August 27, 2015): aac4716. doi:
10.1126/science.aac4716.

Economics
“...We assert
that economics
research is
usually not
replicable.”
— Andrew C. Chang
and Phillip Li,
2015

“Homeless man in
Vancouver” by Jay Black is
licensed under CC BY-SA
2.0.

Economics is another discipline with a reputation for non-reproducibility.
A 2015 paper by two researchers from the Federal Reserve and the Department of
the Treasury tried to replicate results from 67 papers published in 13 prestigious
journals. Even after contacting the authors of the original studies when necessary,
they were only able to replicate 49% of the results. They concluded, “Because we
were able to replicate less than half of the papers in our sample even with help from
the authors, we assert that economics research is usually not replicable.”
Perhaps the best known replication case in economics is this one:
In 2010, Harvard economists Carmen Reinhart and Kenneth Rogoff published a
paper in the American Economic Review that demonstrated that the rate of economic
growth in advanced economies declines precipitously once the level of government
debt exceeds 90 percent of the country’s GDP. Their paper was embraced by
politicians around the world as justification to cut back on stimulus measures after the
2008 crash and to instead implement austerity.
But in 2013 Thomas Herndon, a grad student at UMass Amherst, had a course
assignment to replicate a well-known economics study. He chose Reinhart & Rogoff.
To make a long story short, after pestering Reinhart & Rogoff for their data, Herndon
discovered that spreadsheet coding errors, selective data omissions, and
unconventional statistical techniques by the Harvard researchers had lead to a false
result. In fact, the average GDP growth for advanced economies with public-debt to

GDP ratios over 90 percent is not dramatically different than when debt ratios are
lower.
Sources:
Chang, Andrew C., and Phillip Li. “Is Economics Research Replicable? Sixty
Published Papers from Thirteen Journals Say ‘Usually Not.” Finance and Economics
Discussion Series 2015-083. Washington: Board of Governors of the Federal Reserve
System, 2015. doi: 10.17016/FEDS.2015.083.
Herndon, Thomas, Michael Ash, and Robert Pollin. “Does High Public Debt
Consistently Stifle Economic Growth? A Critique of Reinhart and Rogoff.” Cambridge
Journal of Economics 38, no. 2 (2014): 257-279. doi: 10.1093/cje/bet075.
Reinhart, Carmen M. and Kenneth S. Rogoff. “Growth in a Time of Debt.” American
Economic Review 100, no. 2 (May 2010): 573-78. doi: 10.1257/aer.100.2.573.

Animal studies
“I think it may
have confounded,
to whatever
degree, some
very large
subset of
existing
research.”
— Jeffrey Mogil,
2014
“Lobund Wistar-Rat”
by Janet Stephens is
in the public domain.

Jeffrey Mogil is a neuroscientist who studies pain at McGill University in Montreal.
When the mice in his experiment weren’t experiencing pain as expected, he realized
that the mice that weren’t feeling the pain had been handled by male students.
Subsequent experiments determined that, as the headline in Nature put it, “male
researchers stress out rodents.”
It turns out that being in the presence of men, but not women, caused intense stress
in the animals, which dampened their pain response.
And since almost every animal behavior studied in the lab is affected by stress, this
finding could have broad implications.
As Mogil put it, “I think it may have confounded, to whatever degree, some very large
subset of existing research.”

Sources:
Duhaime-Ross, Arielle. “Lab Mice Fear Men But Not Women, and That’s a Big
Problem for Science.” The Verge. Last modified April 28, 2014.
http://www.theverge.com/2014/4/28/5661118/lab-mice-fear-men-not-women-big-probl

em-for-science.
Katsnelson, Alla. “Male Researchers Stress Out Rodents.” Nature. Last modified April
28, 2014. doi: 10.1038/nature.2014.15106.
Sorge, Robert E., Loren J. Martin, Kelsey A. Isbester, Susana G. Sotocinal, Sarah
Rosen, Alexander H. Tuttle, Jeffrey S. Wieskopf, Erinn L. Acland, Anastassia Dokova,
Basil Kadoura, Philip Leger, Josiane C. S. Mapplebeck, Martina McPhail, Ada
Delaney, Gustaf Wigerblad, Alan P. Schumann, Tammie Quinn, Johannes Frasnelli,
Camilla I. Svensson, Wendy F. Sternberg, and Jeffrey S. Mogil. “Olfactory Exposure
to Males, Including Men, Causes Stress and Related Analgesia in Rodents.” Nature
Methods 11, no. 6 (June 2014): 629-632. doi: 10.1038/nmeth.2935.

Biomedical research

“The NIAMS Cartilage
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BY-NC 2.0.

Reproducibility has also been a big problem in biomedical research, or so-called
“preclinical research.”
Preclinical research describes the type of exploratory, hypothesis-generating research
that goes on at universities (as opposed to clinical research and testing in humans
that may be conducted by drug companies, for example).
In 2011, a team from Bayer reported that in only 20-25% of 67 seminal studies they
tried to reproduce did they come to results “completely in line” with those of the
original publications.
In 2012, Glenn Begley, the former head of cancer research at Amgen, reported that
over a 10 year stretch, Amgen’s scientists had tried to replicate the findings of 53
landmark studies in cancer biology. They obtained positive results in only 6, a rate of
just over 11%.
Ioannidis studied 49 of the most highly-regarded research findings in medicine
published between 1990-2003, each cited more than 1,000 times. These were articles
that helped lead to the widespread popularity of treatments such as the use of
hormone-replacement therapy for menopausal women, vitamin E to reduce the risk of
heart disease, coronary stents to ward off heart attacks, and daily low-dose aspirin to
control blood pressure and prevent heart attacks and strokes. Of the 49 claims, 34
had been re-tested, and 14, or 41% had been convincingly shown to be wrong or
significantly exaggerated.

One analysis of past studies indicates that the total prevalence of irreproducible
preclinical research exceeds 50%, resulting in approximately $28 billion a year spent
on research that is not reproducible, in the United States alone.

Sources:
Begley, C. Glenn, and Lee M. Ellis. “Drug Development: Raise Standards for
Preclinical Cancer Research.” Nature 483 (29 March 2012). 531-533. doi:
10.1038/483531a.
Freedman, David H. “Lies, Damned Lies, and Medical Science.” The Atlantic,
November 2010.
https://www.theatlantic.com/magazine/archive/2010/11/lies-damned-lies-and-medicalscience/308269/.
Freedman, Leonard P., Iain M. Cockburn, and Timothy S. Simcoe. “The Economics of
Reproducibility in Preclinical Research.” PLoS Biology 13, no. 6 (2015): e1002165.
doi:10.1371/journal.pbio.1002165.
Ioannidis, John P. A. “Contradicted and Initially Stronger Effects in Highly Cited
Clinical Research.” JAMA 294 (2005): 218-228. doi: 10.1001/jama.294.2.218.
Prinz, Florian, Thomas Schlange, and Khusru Asadullah. “Believe it or Not: How
Much Can We Rely on Published Data on Potential Drug Targets?” Nature Reviews
Drug Discovery 10, no. 9 (September 2011): 643-644. doi: 10.1038/nrd3439-c1.

Why? “File-drawer problem”
Researchers do not bother to
write up experiments with
negative / null results or the
results of replication studies.
Instead of submitting them to
journals, they file them away.

“Filing” by Jeff Youngstrom is licensed under CC BY-NC 2.0.

File-drawer problem: Researchers do not bother to write up experiments with negative
/ null results or the results of replication studies.
Instead of submitting them to journals, they file them away.
They believe journals are not interested in publishing negative results or replications.
Replication studies are viewed as lacking prestige, originality, or excitement. They
can be seen as a challenge to authority in their field.
Researchers fear that replications and negative results will not get them published,
promoted, or even hired.
Example:
A 2008 study of antidepressant trials registered with the FDA found that almost all
trials showing positive effects of the drugs were published, while trials with negative
results, with few exceptions, remained either unpublished or were published with the
results presented so that they would appear positive.

Sources:
Turner, Erick H., Annette M. Matthews, Eftihia Linardatos, Robert A. Tell, and Robert

Rosenthal. “Selective Publication of Antidepressant Trials and Its Influence on
Apparent Efficacy.” New England Journal of Medicine 358 (2008): 252-260. doi:
10.1056/NEJMsa065779.

Why? Publication bias
“...the small proportion of
results chosen for publication
are unrepresentative of
scientists’ repeated samplings of
the real world.”
— Neal S. Young, John P. A. Iaonnidis,
and Omar Al-Ubaydli, 2008

Cover of Science v. 332, no. 6034 by the American
Association for the Advancement of Science. Image by
Stephen R. White.

Not only are researchers biased against writing up and submitting negative results,
but journals are biased toward publishing positive results.
A 2012 study by Danielle Fanelli of the University of Edinburgh analyzed over 4,600
papers published in all disciplines between 1990 and 2007. She found that the
proportion of positive results increased from 70% in 1990-1991 to 86% in 2007.

Sources:
Fanelli, Daniele. “Negative Results are Disappearing From Most Disciplines and
Countries.” Scientometrics 90, no. 3 (March 2012): 891-904. doi:
10.1007/s11192-011-0494-7.
Young, Neal S., John P. A. Ioannidis, and Omar Al-Ubaydli. “Why Current Publication
Practices May Distort Science.” PLoS Medicine 5, no. 10 (2008): e201. doi:
10.1371/journal.pmed.0050201.

Why? Bad experimental design & analysis
“If you torture
the data long
enough, it will
confess.”
— Ronald Coase,
recipient of the
1991 Nobel Prize in
Economics
“The Relationship Between
Sample Size and Power” by
Online Statistics Education: A
Multimedia Course of Study
is in the public domain.

This slide could be the entire presentation in itself.
To keep it simple, problems with experimental design and data analysis include:
● Using sample sizes that are too small -- while results might be positive, their
statistical power is low
● Failing to state one’s hypothesis in advance of the study, also known as
HARK-ing (hypothesizing after the results are known)
● “P-hacking”
○ Viewing experimental data are they are coming in and stopping the
experiment once a positive result is obtained
○ Performing hundreds of tests on dozens of variables and only reporting
those that produced positive results
● Researchers not using controls or not blinding themselves to study group vs.
control group
● Not attempting to replicate results before publication
● Not documenting experimental methods adequately
● Not making available data and code underlying the experiment
● In biological sciences, not validating reagents, antibodies, cell lines, and other
lab materials

Source:
Wikiquote, s.v. “Ronald Coase.” Accessed March 15, 2017.
https://en.wikiquote.org/wiki/Ronald_Coase.

Why? Incentive structure
“Today I wouldn’t get an
academic job. It’s as simple as
that. I don’t think I would be
regarded as productive enough.”
— Peter Higgs, 2013 (winner of the
2013 Nobel Prize in Physics)

“Prof. Meyerson in his funky Stanford gown” by Anna
Majkowska is licensed under CC BY 2.0.

Perhaps the biggest reason for the reproducibility crisis is the incentive structure for
academic researchers.
Researchers know that they need to publish regularly in the most prestigious journals
possible in order to get tenure and receive grants.
● Due to the intense competition for academic research positions, there have
been persistent increases in the average number of publications at the time of
hiring.
Because high-prestige journals like to publish exciting, surprising, or “sexy,” results,
there is incentive to test hypotheses that are unlikely.
● In the years between 1974 and 2014, the frequency of the words “innovative,”
“groundbreaking,” and “novel” in PubMed abstracts increased by 2500% or
more.
To make sure a hypothesis has firm theoretical grounding and an experimental design
is well powered slows down the rate of production, so sound science is discouraged.
Shai Silberberg of the NIH notes that, “As long as universities think that the way for
investigators to get money is to publish in Nature and Science, then that’s what
they’re going to look for in investigators. They want that money.”

Sources:
Aitkenhead, Decca. “Peter Higgs: I Wouldn’t Be Productive Enough for Today’s
Academic System.” The Guardian (London), December 6, 2013.
https://www.theguardian.com/science/2013/dec/06/peter-higgs-boson-academic-syste
m.
Smaldino, Paul E. and Richard McElreath. “The Natural Selection of Bad Science.”
Royal Society Open Science 3 (2016): 160384. doi: 10.1098/rsos.160384.
Voosen, Paul. “Amid a Sea of False Findings, the NIH Tries Reform.” The Chronicle
of Higher Education. Last modified: March 16, 2015.
http://www.chronicle.com/article/Amid-a-Sea-of-False-Findings/228479/.

What about peer review?
“We need to get away from
the notion, proven wrong on
a daily basis, that peer
review of any kind at any
journal means that a work of
science is correct.”
— Michael Eisen, 2014

“Peer Review Monster” by Gideon Burton is licensed
under CC BY-SA 2.0.

The problems with peer review would also require a separate presentation. Just some
highlights:
The Cochrane Collaboration reviewed the evidence on peer review of manuscripts
and grant proposals. They concluded, “At present, little empirical evidence is available
to support the use of editorial peer review as a mechanism to ensure quality of
biomedical research.”
The British Medical Journal took a study that was about to be published and inserted
8 errors in it, then sent it out to 300 reviewers. The median number of errors spotted
was two, and 20% of the reviewers did not spot any.
And, one of the best well-known failures of peer review was the article by Andrew
Wakefield, published in The Lancet in 1998, finding that the MMR vaccine caused
autism. That article was reviewed by 6 reviewers, none of whom found any of the
problems with it that were later identified.
In short, peer review fails to detect false research findings primarily because:
● Reviewers don’t re-run the experiments or examine the data, and they can
have no knowledge as to what data investigators have chosen to exclude.
● And again, incentives: Reviewing is not highly valued for career advancement
— thus diligence in reviewing and time spent are not rewarded.

[Alternatives: Publish everything and then let the world decide what is important;
post-publication peer review; increased transparency; credit for reviewers.]

Sources:
Campbell, Hank. “The Corruption of Peer Review is Harming Scientific Credibility.”
Wall Street Journal (New York, NY), July 14, 2014.
Houses of Parliament, Parliamentary Office of Science & Technology. “Integrity in
Research.” POSTnote 544 (January 2017).
http://researchbriefings.files.parliament.uk/documents/POST-PN-0544/POST-PN-054
4.pdf.
Kabat, Geoffrey. “The Crisis of Peer Review.” Forbes. Last modified November 23,
2015. http://onforb.es/1QDzpVj.
Smith, Richard. “Classical Peer Review: An Empty Gun.” Breast Cancer Research 12,
suppl. 4 (2010): S13. doi: 10.1186/bcr2742.
Wakefield, A. J., S. H. Murch, A. Anthony, J. Linnell, D. M. Casson, M. Malik, M.
Berelowitz, A. P. Dhillon, M. A. Thomson, P. Harvey, A. Valentine, S. E. Davies, and
J. A. Walker-Smith. “Ileal-Lymphoid-Nodular Hyperplasia, Non-Specific Colitis, and
Pervasive Developmental Disorder in Children.” The Lancet 351, no. 9103 (February
28, 1998): 637-641. doi: 10.1016/S0140-6736(97)11096-0.

Proposed solutions: Registered reports

Image source: Center for Open Science, https://cos.io/rr/.

Registered reports are an initiative of the Center for Open Science. Over 49 journals
now offer them. Researchers can also use the Center for Open Science’s Open
Science Framework to register their research.
Here’s how it works:
Journals agree to review a study’s design and analysis plan before the experiment is
conducted.
The study design is itself peer reviewed and must be methodologically sound and
address an important scientific question.
Approved studies will be published as long as the study protocols were followed,
regardless of the findings.
Therefore, publication is based not on results but on an experiment’s methods and
rigor.
This eliminates publication bias toward positive results as well as questionable
research practices.
Similar initiatives are:
● ClinicalTrials.gov, started in 2000 and run by the National Library of Medicine.

●
●

It is a registry of over 230,000 clinical trials from 195 counties in the world. It
addresses the problem of pharmaceutical companies not sharing negative
results of their drug trials.
AllTrials, started in 2013, is a campaign advocating that all clinical trials,
including past trials, be listed in a clinical trials registry, and that their results
be shared openly.

Sources:
“AllTrials.” Accessed March 10, 2017. http://www.alltrials.net/.
Center for Open Science, “Open Science Framework.” Accessed March 16, 2017.
https://osf.io/.
Center for Open Science, “Registered Reports.” Accessed March 15, 2017.
https://cos.io/rr/.
Chambers, Chris. “Cortex’s Registered Reports.” Elsevier Connect. Last modified
March 11, 2015.
https://www.elsevier.com/editors-update/story/peer-review/cortexs-registered-reports.
Wikipedia, s.v. “ClinicalTrials.gov.” Accessed March 15, 2017.
https://en.wikipedia.org/wiki/ClinicalTrials.gov.

Proposed solutions: Funding & publishing
replications, publishing negative results

Image source: Center for
Open Science,
https://cdn.cos.io/static/imag
es/cos_stack.png

Funding and publishing replication studies:
Funding agencies should fund replication studies, and journals should publish them.
One current example is the Reproducibility Project: Cancer Biology.
● Launched in 2013 with a $2 million grant from the Laura and John Arnold
Foundation, it is a collaboration between the Center for Open Science and the
Science Exchange.
● Researchers are independently replicating a subset of experimental results
from a number of high-profile papers in the field of cancer biology published
between 2010-2012.
● So far, five replications, with mixed results, have been published in the journal
eLife.
Some journals have created sections devoted to replications, for example
Perspectives on Psychological Science.

Publishing negative / null results:
Referees and journal editors should value negative / null results and publish them.
Before publishing positive results, journals should require demanding reproducibility
criteria, such as an independent replication.

A number of new journals or collections within journals have been established to
specialize in publishing negative results, e.g.:
● Elsevier’s New Negatives in Plant Science
● PLoS One’s Positively Negative collection
● Biomed Central’s Journal of Negative Results in Biomedicine
At the very least, we need rapid, digital publication of all articles that contain no flaws,
irrespective of perceived importance.
● PLoS One is one journal that asks peer reviewers only if a paper is
methodologically sound.

Replication studies and negative / null results can also be shared on preprint servers
such as ArXiv, bioRxiv, SocArXiv, engrXiv, and SSRN.
The goal should be for the results of all research to be discoverable, even if not
formally published.

Sources:
Aschwanden, Christie. “Failure is Moving Science Forward.” FiveThirtyEight. Last
modified March 24, 2016.
https://fivethirtyeight.com/features/failure-is-moving-science-forward/.
Baker, Monya and Elie Dolgin. “Reproducibility Project Yields Muddy Results.” Nature
541 (January 19, 2017): 269-270. doi: 10.1038/541269a.
Center for Open Science. “Reproducibility Project: Cancer Biology (RP:CB)
Overview.” Accessed March 1, 2017.
https://cos.io/our-services/research/rpcb-overview/.
Munafò, Marcus R., Brian A. Nosek, Dorothy V. M. Bishop, Katherine S. Button,
Christopher D. Chambers, Nathalie Percie du Sert, Uri Simonsohn, Eric-Jan
Wagenmakers, Jennifer J. Ware, and John P. A. Ioannidis. “A Manifesto for
Reproducible Science.” Nature Human Behavior 1 (January 2017): 0021. doi:
10.1038/s41562-016-0021.
Young, Neal S., John P. A. Ioannidis, and Omar Al-Ubaydli. “Why Current Publication
Practices May Distort Science.” PLoS Medicine 5, no. 10 (2008): e201. doi:
10.1371/journal.pmed.0050201.

Proposed solutions: Open data, open access

Image source: Registry of Research Data
Repositories, http://www.re3data.org/.

Data and software code underlying an article should be openly shared.
There are a growing number of public data repositories available, and the Center for
Open Science’s Open Science Framework also provides tools for sharing.
In fact, open data should be mandatory as a condition of publication.
Fortunately, many funders and journals now make sharing data a requirement.
(Though a 2011 study found that of 351 papers published in 2009 in journals with a
data availability policy, only 41% fully complied.)
This is also good for the preservation of the scholarly record.
● One group of researchers, lead by Timothy Vines, reached out to the
investigators behind over 500 research papers published between 1991 and
2001. They found that just 23% of the data still existed, and that the odds of a
data set still existing fell by 17% per year.
Of course, open access to the articles themselves is also good for reproducibility.
Open access can be provided by publishing in an open access journal or by posting
article manuscripts to preprint servers or repositories.

Sources:

Alsheikh-Ali, Alawi A., Waqas Qureshi, Mouaz H. Al-Mallah, John P. A. Ioannidis.
“Public Availability of Published Research Data in High-Impact Journals.” PLoS One
6, no. 9 (2011): e24357. doi: 10.1371/journal.pone.0024357.
Center for Open Science, “Open Science Framework.” Accessed March 16, 2017.
https://osf.io/.
Open Science Collaboration. “Maximizing the Reproducibility of Your Research.” In
Psychological Science Under Scrutiny: Recent Challenges and Proposed Solutions,
edited by Scott O. Lilienfeld and Irwin D. Waldman, 3-21. New York: Wiley, 2017.
Munafò, Marcus R., Brian A. Nosek, Dorothy V. M. Bishop, Katherine S. Button,
Christopher D. Chambers, Nathalie Percie du Sert, Uri Simonsohn, Eric-Jan
Wagenmakers, Jennifer J. Ware, and John P. A. Ioannidis. “A Manifesto for
Reproducible Science.” Nature Human Behavior 1 (January 2017): 0021. doi:
10.1038/s41562-016-0021.
“Registry of Research Data Repositories.” Accessed March 16, 2017.
http://www.re3data.org/.
Vines, Timothy H., Arianne Y. K. Albert, Rose L. Andrew, Florence Débarre, Dan G.
Bock, Michelle T. Franklin, Kimberly J. Gilbert, Jean-Sébastien Moore, Sébastien
Renaut, and Diana J. Rennison. “The Availability of Research Data Declines Rapidly
with Article Age.” Current Biology 24, no. 1 (6 January 2014): 94-97. doi:
10.1016/j.cub.2013.11.014.

Proposed solutions: Better study designs &
statistical methods

“Cell Culture” by Umberto Salvagnin is
licensed under CC BY 2.0.

Some highlights:
● Distinguish exploratory studies from hypothesis-testing studies. Hypotheses
can only be tested after they have been formulated.
● Design confirmatory studies with larger sample sizes for higher statistical
power; one way is to collaborate with groups at other institutions to run the
study.
● Utilize good scientific methods (e.g. blinding, controls, repeats).
● Create a plan for data analysis before observing the data.
● Describe methods in more detail to increase others’ ability to reproduce the
results. Several journals now offer checklists of information that should be
included.
● Validate materials used in the lab, e.g. cell lines, antibodies, specialty
chemicals.
● Improve training in experimental design and statistical techniques for grad
students, post-docs, and even researchers, because best practices are
constantly evolving.

Sources:
Begley, C. Glenn and John P. A. Ioannidis. “Reproducibility in Science: Improving the
Standard for Basic and Preclinical Research.” Circulation Research 116, no. 1

(January 2015): 116-126. doi: 10.1161/CIRCRESAHA.114.303819.
Ioannidis, John P. A. “How to Make More Published Research True.” PLoS Medicine
11, no. 10 (October 2014): e1001747. doi: 10.1371/journal.pmed.1001747.
Munafò, Marcus R., Brian A. Nosek, Dorothy V. M. Bishop, Katherine S. Button,
Christopher D. Chambers, Nathalie Percie du Sert, Uri Simonsohn, Eric-Jan
Wagenmakers, Jennifer J. Ware, and John P. A. Ioannidis. “A Manifesto for
Reproducible Science.” Nature Human Behavior 1 (January 2017): 0021. doi:
10.1038/s41562-016-0021.
Open Science Collaboration. “Maximizing the Reproducibility of Your Research.” In
Psychological Science Under Scrutiny: Recent Challenges and Proposed Solutions,
edited by Scott O. Lilienfeld and Irwin D. Waldman, 3-21. New York: Wiley, 2017.
Voosen, Paul. “Amid a Sea of False Findings, the NIH Tries Reform.” The Chronicle
of Higher Education. Last modified: March 16, 2015.
http://www.chronicle.com/article/Amid-a-Sea-of-False-Findings/228479/.

Proposed solutions: Slow science
“Scrupulous research
on difficult problems
may require years of
intense work before
yielding coherent,
publishable results.”
— Paul E. Smaldino and
Richard McElreath, 2016
“Weinbergschnecke” by
Jürgen Schoner is
licensed under CC
BY-SA 3.0.

Research culture and career incentives need to be changed:
Researchers should be assessed for career advancement and funding decisions on
the quality of their work, not on the quantity of publications they’ve written or journal
impact factor or brand.
Those who conduct rigorous, transparent and reproducible research should be
rewarded more than those who do not, and researchers need to be held accountable
for acknowledging mistakes.
Systems should be developed that finance individual investigators over the longer
term rather than specific projects.
[Would require less austerity in higher education, more funding, more positions, to
tone down hyper-competitive culture.]

Sources:
Begley, C. Glenn and John P. A. Ioannidis. “Reproducibility in Science: Improving the
Standard for Basic and Preclinical Research.” Circulation Research 116, no. 1
(January 2015): 116-126. doi: 10.1161/CIRCRESAHA.114.303819.
Ioannidis, John P. A. “How to Make More Published Research True.” PLoS Medicine

11, no. 10 (October 2014): e1001747. doi: 10.1371/journal.pmed.1001747.
Munafò, Marcus R., Brian A. Nosek, Dorothy V. M. Bishop, Katherine S. Button,
Christopher D. Chambers, Nathalie Percie du Sert, Uri Simonsohn, Eric-Jan
Wagenmakers, Jennifer J. Ware, and John P. A. Ioannidis. “A Manifesto for
Reproducible Science.” Nature Human Behavior 1 (January 2017): 0021. doi:
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How does this connect with “fake news”?
• Consumption of “fake” and
low quality information is
not limited to the uneducated
or ignorant.
• “Fake results” of research
undermine public trust in
expertise and established
knowledge.
“Invasion of Fake News” by Free Press/ Free
Press Action Fund is licensed under CC
BY-NC-SA 2.0.

The highly educated also deal in false information, though in most cases this is not
deliberate, rather the result of structural problems.
We have all heard of expert advice based on scientific studies that has turned out not
to be true: advice on diet, safety of drugs, effectiveness of medical interventions, etc.

See:
Nichols, Tom. The Death of Expertise: The Campaign Against Established Knowledge
and Why It Matters. New York: Oxford University Press, 2017.

Closing thoughts
“As readers of scientific work, all we can do is be more
skeptical of everything that is published.”
— Christobal Young, Assistant Professor of Sociology, Stanford
University, 2015

“I want to adopt a stance of humility and assume that there
are errors and that’s why I need to be cautious in my
conclusions.”
— Brian Nosek, Professor of Psychology, University of Virginia and
co-founder and director of the Center for Open Science, 2016

Be critical: We can view research claims with a critical eye, educate ourselves on
basic ways of evaluating research quality.
Be humble: Don’t arrogantly assume that we have figured everything out and have all
the answers, because we usually don’t.
Be willing to revise our own personal opinions: We should be able to disconnect our
positions from our identities, not stake our sense of self on a particular position we
hold or practice that we’ve embraced.
Push for openness and transparency in the production and dissemination of
knowledge.

Sources:
Aschwanden, Christie. “Failure is Moving Science Forward.” FiveThirtyEight. Last
modified March 24, 2016.
https://fivethirtyeight.com/features/failure-is-moving-science-forward/.
Flaherty, Colleen. “Landmark Study Suggests Most Psychology Studies Don’t Yield
Reproducible Results.” Inside Higher Ed. Last modified August 28, 2015.
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Closing thoughts
“The facts that science denialists target are almost always
very different from the types of facts we are modeling. We
are modeling small-scale facts of modest import. The
reality of anthropogenic climate change, the lack of
connection between vaccination and autism, or the causative
role of smoking in cancer are very different. Facts of this
sort have enormous practical importance; they are supported
by massive volumes of research.”
— Silas Boye Nissen, Tali Magidson, Kevin Gross, and Carl T.
Bergstrom, 2016

Finally, the reproducibility crisis, though real and pervasive, is not to be confused with
scientific denialism.
Replication problems are not an issue in areas such as human-induced climate
change and natural selection that have been verified by thousands of scientists over
many years.
So, this presentation is not a repudiation of the scientific method, but rather a call to
better live up to it.

Sources:
Nissen, Silas Boye, Tali Magidson, Kevin Gross, and Carl T. Bergstrom. “Publication
Bias and the Canonization of False Facts.” eLife 5 (2016): e21451. doi:
10.7554/eLife.21451.
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